【CPHI Shanghai】Haibu P  × harmaceutical is eagerl' ₩y waiting at booth E6E25!

Beijing Haibu Pharmaceutic≈©al Technology Co., Ltd. (refe☆♦☆™rred to as 'Haibu Pharma←>ceutical') was established in 2005 ↓≈λand is a high-tech ente£εrprise with 'chemical drug R&D'∏"Ω♣ as its core capability. It has a•≥∞∑ research and development cen€✘☆ter in Beijing, a piloπ‌ ₩t validation center for raw ma™γ terials and formulations, and a ®£♠GMP industrial production bas¶✔ε"e, mainly engaged in¥' CRO services for raw materials and÷‍ formulations, MAH jo→✔int licensing, raw ma∞≠terial-related applications, an'₽βd commercial supply of p™∞₽harmaceutical intermedi♦Ω•ates.It has rich experience ♥∞in the R&D transfer production, re←÷gistration application,↓★&δ etc., of various do₹♦sage forms such as chemλ£€ical raw materials, oral solids, li ≤₹Ωquid preparations, sterile injection §s, and external preparations. Th> &∞e R&D products cover mu→ ✔∏ltiple therapeutic areas incluπ₽ding anti-tumor, ant♦αi-depression, anti-epilepsy, anλαti-anxiety, cardiovascuβ↓ →lar and cerebrovascular di₽δ₽seases, digestive sy♠₹×δstem diseases, respiratory system®÷ diseases.

Haibu Pharmaceutical has β♥been awarded the title of 'Top 20 Ch‌≥∑inese Pharmaceutical R&¥>​φD Companies' for many years and re&✘$¶cognized as a 'Specialized & Inεש✔novative Enterprise' by Beijin★"↕ g Municipality, a 'National High-tech E→♠​nterprise', a 'Beijing Science and ​✘ >Technology Research De✘™→velopment Institutio¶ §"n', and a 'Beijing Yizhuang E♠≤γnterprise Innovation Center', amon∏↔$ g others.